Guangzhou Jida

Guangzhou Jida Biotechnology is a leading Chinese biopharmaceutical company focused on the development and commercialization of recombinant protein drugs and bioactive peptides. Closely affiliated with Jinan University and the National Engineering Research Center of Genetic Medicine, the company specializes in growth factor therapies for tissue repair and wound healing. Its flagship product, rhEGF, is widely used in China for treating various skin wounds, burns, and surgical incisions. The company's pipeline includes rhKGF-2 for corneal injuries and oral mucositis, as well as proprietary peptides like TVigour A for skin barrier restoration and fibroblast targeting. Guangzhou Jida operates as a high-tech enterprise with strong R&D capabilities in genetic engineering and protein modification. The company is headquartered in Guangzhou and maintains a significant presence in the regional biotech ecosystem through its research and manufacturing facilities.